Ekso Bionics Holdings Inc

Ekso Bionics Holdings Inc

EKSO

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.31B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ekso Bionics Holdings IncEkso Bionics Holdings Inc0--966%-1
$4.71

Current Fair Value

70.4% downside

Overvalued by 70.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.31 Billion
Enterprise Value$2.31 Billion
Dividend Yield$- (NaN%)
Earnings per Share$-4.91
Beta0.82
Outstanding Shares145,407,573

Return

Return on Equity-966.27%ROE
Return on Assets-282.00%
Return on Invested Capital-366.69%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue45.38
Enterprise Value to EBIT-59.66
Enterprise Value to Net Income-42
Total Debt to Enterprise0
Debt to Equity1.03Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 3, 2026
EPS Estimate
$-0.06
Average shareholder expectation
Revenue Estimate
$2.51 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %30.20%▲ 4.63%
Total Invested$23.91M▲ 38.82%
Investors Holding46▲ 15.00%

ESG Score

No data

About ChronoScale Corporation

61 employees
CEO: Ying Cenly Chen

ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, con...